Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
gptkb:Invitae_Corporation
|
| gptkbp:awards |
Best Places to Work
|
| gptkbp:clinicalTrials |
ongoing
completed planned |
| gptkbp:collaborations |
academic institutions
|
| gptkbp:communityEngagement |
educational initiatives
patient advocacy outreach programs |
| gptkbp:employees |
over 100
|
| gptkbp:focus |
genomic testing
|
| gptkbp:founded |
2013
|
| gptkbp:founder |
gptkb:David_E._K._H._Archer
|
| gptkbp:futurePlans |
innovation
expansion new product development |
| gptkbp:headquarters |
gptkb:Boulder,_Colorado
|
| https://www.w3.org/2000/01/rdf-schema#label |
ArcherDX
|
| gptkbp:industry |
healthcare
|
| gptkbp:investmentFocus |
venture capital
strategic partnerships private equity |
| gptkbp:location |
gptkb:United_States
|
| gptkbp:market |
personalized medicine
diagnostic testing pharmaceutical development |
| gptkbp:partnerships |
gptkb:Thermo_Fisher_Scientific
laboratories biopharmaceutical companies clinical research organizations healthcare_providers |
| gptkbp:products |
gptkb:Oncomine
gptkb:Archer_FusionPlex Archer VariantPlex |
| gptkbp:publications |
conference proceedings
scientific journals white papers |
| gptkbp:regulatoryCompliance |
CAP_accredited
CLIA_certified |
| gptkbp:research |
grants
collaborative projects government funding |
| gptkbp:researchFocus |
precision medicine
|
| gptkbp:services |
clinical diagnostics
research applications |
| gptkbp:specialization |
cancer genomics
|
| gptkbp:sustainability |
ethical standards
social responsibility environmental practices |
| gptkbp:technology |
bioinformatics
next-generation sequencing targeted therapy liquid biopsy |
| gptkbp:website |
www.archerdx.com
|